Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – online resources
    • IMPACT
      • Workshops
      • IMPACT – online resources
      • IMPACT news
      • IMPACT partners and sponsors
    • SPECC
      • Workshops
      • Online resources
      • SPECC Partners and Sponsors
      • SPECC News
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • PELT
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
        • How your donations are spent
    • Events and Challenges
    • Leaving a Legacy
    • Fundraising
      • Our fundraisers
      • Fundraising pack
      • Fundraising opportunities
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Online Shop
  • Events
  • Contact us

Expert view – colostomy

Here, Professor RJ (Bill) Heald considers a question frequently asked by patients*.

Q: Do I really need a permanent colostomy?

‘If you have rectal cancer, the height of your tumour above the bottom of your anal canal influences whether you will need a permanent colostomy or not. Your surgeon will always write down the height of your tumour – so it is reasonable to ask him or her what this height is, as it makes a major difference to your future.

Examples:

  1. Around 2 – 3 centimetres. Cancers with their lower edge this low down will almost always require abdomino-perineal excision and permanent colostomy, with the exception of some rather uncommon tumours that can sometimes be completely controlled with chemoradiotherapy.
  2. 4 – 6 centimetres. Some specialists will be prepared to perform an operation that preserves the anal canal and restores colorectal continuity or even joins a colon “pouch” on to the anal canal itself, thus restoring relatively normal anal function. In these cases where a permanent colostomy is being suggested, a second opinion is a really sensible course of action, which should give no offence to the surgeon concerned.
  3. 7 – 12 centimetres. Tumours this far into the rectum will almost always be suitable for a restorative procedure (which allows the bowel to be joined together) which requires at the most a temporary protective colostomy or ileostomy. This should ultimately lead to relatively normal bowel function after the primary treatment has been concluded and the stoma closed. Again, if a permanent colostomy is recommended a second opinion is appropriate.
  4. 12 – 15 centimetres and above. These cancers are in general more simple to understand and manage: removal and re-joining is generally possible.

If you do need a permanent colostomy, you may wish to consider the possibility of irrigation. Irrigation is a way of regulating your bowel movements by emptying the colon at a scheduled time. Many patients find that irrigation brings a welcome sense of freedom and normality to life with a colostomy.’

To read more about irrigation, click here.

* Please note that this is a general answer applying to Basingstoke practice. If you have questions or concerns about your specific diagnosis and treatment, you should talk to your specialist nurse.

Pelican Cancer FoundationFollow

Pelican Cancer Foundation
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
22 Dec

We would like to wish you all a very Merry Christmas and a peaceful New Year - especially to all the wonderful key workers, who will be working throughout. 🎄🥂🎁

Reply on Twitter 1341352794255593477Retweet on Twitter 1341352794255593477Like on Twitter 13413527942555934771Twitter 1341352794255593477
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
7 Dec

👏

Reply on Twitter 1335864743752589312Retweet on Twitter 1335864743752589312Like on Twitter 13358647437525893122Twitter 1335864743752589312
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
5 Dec

Let loved ones know that you are thinking of them over the festive period and send a handwritten Christmas card. Order your Christmas cards from us at http://www.pelicancancer.org/shop. 🎄(Royal Mail’s latest recommended posting dates are 18th Dec (2nd Class) and 21st Dec (1st Class). 🎄

Reply on Twitter 1335126762079068160Retweet on Twitter 1335126762079068160Like on Twitter 1335126762079068160Twitter 1335126762079068160
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in